Osaic Holdings’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Other funds holding KPTI
ACA
Osaic Holdings's KPTI Position: Q3 2026 in Review
Osaic Holdings held its Karyopharm Therapeutics (KPTI) position steady in Q3 2026 at 402 shares worth $490. The position accounts for ﹤0.01% of the portfolio, ranked #7723.
Osaic Holdings first reported a position in KPTI in Q1 2020 and has held it in 27 quarters since. The position peaked at $477K in Q2 2020. 92 funds tracked by Wall St. Rank hold KPTI as of Q3 2026.
- Osaic Holdings held 402 shares of Karyopharm Therapeutics worth $490 as of Q3 2026.
- Osaic Holdings left its Karyopharm Therapeutics share count unchanged in Q3 2026.
- Karyopharm Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7723 holding.
- Osaic Holdings first reported a position in Karyopharm Therapeutics in Q1 2020 and has held it in 27 quarters since.
- Osaic Holdings's Karyopharm Therapeutics position peaked at $477K in Q2 2020.
- 92 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.